Study Atlas
Study accountPrivacySaved locally

Tropical Medicine

Peptic ulcer disease

Tropical Medicine

High Yield45 min lesson estimate89 question families

Well covered in the main question banks · 82 main-bank entries · 63 linked PDF entries · 0 generated drills

Curriculum reference · Official College Textbook – Digestive Disorders – Part 1, pp. 58–68. Lesson adapted from Internal Medicine and Tropical Medicine.

Topic map

  • Mucosal defensesmucus, bicarbonate, prostaglandins and blood flow
  • CausesH. pylori, NSAIDs, stress injury, hypersecretion
  • Complicationsbleeding, perforation, penetration or obstruction
  • Work-upactive infection tests, endoscopy and targeted treatment

Scroll the diagram to see all labels.

Peptic-ulcer sites and duodenal complicationsAn ulcer in the bulb can perforate anteriorly or reach the gastroduodenal artery posteriorly. StomachGastric ulcerDuodenal bulb Anterior perforationPosterior bleeding
Peptic-ulcer sites and duodenal complicationsAn ulcer in the bulb can perforate anteriorly or reach the gastroduodenal artery posteriorly.

Definition, sites and mechanisms

A peptic ulcer is a mucosal defect that extends through the muscularis mucosae, unlike a superficial erosion. The course includes stomach and proximal duodenum (especially bulb), distal esophagus, gastrojejunal margins and acid-producing ectopic gastric mucosa in Meckel diverticulum. The cecum is not a usual PUD site [IM Mid Q5]. Normal protection includes mucus [IM Dept Q2], bicarbonate, prostaglandins, epithelial restitution and blood flow. Acid, pepsin, infection and drugs can overcome that protection.

Helicobacter pylori [IM Mid Q2/Q11/Q14 · IM Dept Q3–4] is a curved gram-negative microaerophilic organism. Urease splits urea, generating ammonia that buffers local acidity. Antral-predominant infection can reduce somatostatin, raise gastrin and increase duodenal acid exposure. Corpus-predominant or extensive gastritis can impair gastric mucosal defenses and produce atrophy. The text estimates that 10–15% of infected people develop ulceration [IM Dept Q3]. It links infection to distal/noncardia gastric adenocarcinoma and gastric MALT lymphoma. GERD and proximal gastric tumors are the comparison exceptions in this bank. Historic prevalence figures vary by place and time.

NSAIDs inhibit COX-1 and reduce mucosal prostaglandins [IM Mid Q1/Q6 · IM Dept Q5]. Risk increases with prior ulcer, older age, higher exposure and combinations such as antithrombotics or corticosteroids. Smoking impairs healing. Severe physiological stress can cause stress-related mucosal injury in critically ill patients (classical burns and CNS injury examples). Ordinary psychological stress can aggravate symptoms and does not establish PUD. Zollinger–Ellison syndrome [IM Mid Q7/Q24] is gastrin-secreting NET with acid hypersecretion, multiple/refractory or distal ulcers, thick folds and possible diarrhea. Measure fasting gastrin with gastric acidity and account for PPI effects and atrophic gastritis. Specialist secretin testing and localization may be needed; consider MEN1.

Symptoms and complications

Nocturnal epigastric pain relieved by meals or antacids [IM Mid Q15/Q17–19/Q22] is the classic duodenal pattern, often recurring a few hours after meals. Pain worsened after eating, food avoidance or weight loss [IM Mid Q23/Q25] can suggest gastric ulcer, but symptom timing cannot reliably diagnose the site. Ulcers can be silent until anemia, hematemesis, melena, hypotension or another complication. NSAID exposure with hematemesis and hypotension [IM Mid Q1] indicates urgent upper GI bleeding.

Posterior duodenal ulcers can erode the gastroduodenal artery or penetrate the pancreas, causing bleeding or persistent back pain. Anterior perforation classically causes abrupt severe pain, guarding and free subdiaphragmatic gas [IM Mid Q16/Q25–26]. Free air establishes perforation concern and does not alone identify which organ perforated. Edema or chronic scarring near the pylorus can cause outlet obstruction with early satiety, retained food, nonbilious vomiting and chloride-depletion alkalosis.

Tests and management

Initial assessment
Active H. pylori testing when suitable; assess alarm features
Confirmation or next test
Endoscopy with appropriate biopsy or therapy for concerning symptoms or complications

Upper endoscopy [Book I pp. 63–65] visualizes ulcers, samples suspicious gastric lesions, and treats bleeding. Gastric ulcers need appropriate biopsy and healing assessment to exclude malignancy. Typical duodenal ulcers are rarely malignant. Barium can show a crater but cannot biopsy or treat. For active H. pylori, use urea breath test or stool antigen [IM Mid Q3/Q9/Q13/Q20/Q30], or endoscopic histology/rapid urease when indicated. Serology reflects exposure and cannot confirm eradication. Unexplained iron deficiency anemia is a testing indication in the relevant context. PPIs, bismuth or antibiotics can cause false negatives.

Use PPIs for ulcer healing, review NSAID necessity and eradicate H. pylori. The bank’s PPI + clarithromycin + amoxicillin [IM Mid Q4] is the classic triple regimen. Current ACG guidance generally favors 14-day optimized bismuth quadruple therapy (PPI, bismuth, tetracycline, metronidazole) when susceptibility is unknown and reserves clarithromycin-based triple therapy for appropriate susceptible infection. Choice depends on local resistance, allergies and prior treatment. Verify cure at least four weeks after antibiotics, off PPI/PCAB for about two weeks and off antibiotics/bismuth for four weeks as appropriate.

Bleeding requires resuscitation and timely endoscopy after stabilization. Treat active bleeding or visible vessels endoscopically, then high-dose PPI for high-risk findings. Consider repeat endoscopy, embolization or surgery for uncontrolled/recurrent bleeding. Peritonitis with perforation needs urgent surgical assessment, resuscitation and antimicrobial therapy. Persistent benign outlet obstruction may require endoscopic dilation or surgery. Older medical/surgical options in Book I include H2 blockers, mucosal protection and acid-reducing procedures; modern care targets the etiology and complication.

Exam traps

For noninvasive active infection, breath testing and stool antigen can both be valid; match the question’s indication and choices. Symptomatic improvement after eradication does not prove cure. Free air changes urgency regardless of the suspected ulcer site.

Diagnostic and management pathways

  • Epigastric symptoms → check bleeding, peritonitis and malignancy alarms
  • Stable and appropriate for noninvasive testing → stool antigen or breath test
  • Alarm, bleeding or suspicious gastric lesion → endoscopy and tissue when indicated
  • Treat ulcer and cause → confirm H. pylori eradication and gastric ulcer healing as appropriate

Compare at a glance

PatternClassic cluePriority
Duodenal ulcerLate/nocturnal pain, food reliefEtiology and active H. pylori testing
Gastric ulcerMeal-related pain or weight lossEndoscopy and appropriate biopsy
PerforationSudden pain, rigidity, free airUrgent surgical assessment
GastrinomaRefractory disease, high fasting gastrin with low gastric pHSpecialist biochemical evaluation

Supplementary clarification – not directly stated in the uploaded materials. Clinical references · ACG H. pylori guideline highlights · ACG upper gastrointestinal and ulcer bleeding guideline

Exam words

  • cecum is not a usual PUD site [IM Mid Q5]
  • mucus [IM Dept Q2]
  • Helicobacter pylori [IM Mid Q2/Q11/Q14 · IM Dept Q3–4]
  • 10–15% of infected people develop ulceration [IM Dept Q3]
  • NSAIDs inhibit COX-1 and reduce mucosal prostaglandins [IM Mid Q1/Q6 · IM Dept Q5]
  • Zollinger–Ellison syndrome [IM Mid Q7/Q24]
  • Nocturnal epigastric pain relieved by meals or antacids [IM Mid Q15/Q17–19/Q22]
  • Pain worsened after eating, food avoidance or weight loss [IM Mid Q23/Q25]
  • hematemesis and hypotension [IM Mid Q1]
  • free subdiaphragmatic gas [IM Mid Q16/Q25–26]
  • Upper endoscopy [Book I pp. 63–65]
  • urea breath test or stool antigen [IM Mid Q3/Q9/Q13/Q20/Q30]
  • PPI + clarithromycin + amoxicillin [IM Mid Q4]

Practice questions

Rapid revision sheet

Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.

  • cecum is not a usual PUD site [IM Mid Q5]
  • mucus [IM Dept Q2]
  • Helicobacter pylori [IM Mid Q2/Q11/Q14 · IM Dept Q3–4]
  • 10–15% of infected people develop ulceration [IM Dept Q3]
  • NSAIDs inhibit COX-1 and reduce mucosal prostaglandins [IM Mid Q1/Q6 · IM Dept Q5]
  • Zollinger–Ellison syndrome [IM Mid Q7/Q24]

Official College Textbook – Digestive Disorders – Part 1, pp. 58–68

Active recall

What are the two common modifiable causes to look for in a patient with a peptic ulcer?

Helicobacter pylori infection and exposure to nonsteroidal anti-inflammatory drugs. Address the cause as well as promoting ulcer healing.

Official College Textbook – Digestive Disorders – Part 1, pp. 58–68

Recall the diagnostic and management pathway from memory.

Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.

  • Epigastric symptoms → check bleeding, peritonitis and malignancy alarms
  • Stable and appropriate for noninvasive testing → stool antigen or breath test
  • Alarm, bleeding or suspicious gastric lesion → endoscopy and tissue when indicated
  • Treat ulcer and cause → confirm H. pylori eradication and gastric ulcer healing as appropriate
↑